To corroborate this point, this review draws parallels between the mechanisms and effects of two gold-standard treatments for diabetes and depression, and the signaling pathways mobilized by the closure of TREK-1 background K+ channels through PE/spadin interaction. Here, KCNK2 is linked to depressive disorder.